SCHEMBL741482

SCHEMBL741482

CN1CCC(Oc2ccc(C(=O)Nc3n[nH]c4sc(C(=O)NC(C)(C)c5cccc(F)c5)cc34)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.49
FLT3 P36888 7/20 0.47
KIT P10721 7/20 0.47
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
NTRK1 P04629 1/20 0.42
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CCNA1 P78396 1/20 0.41
INSR P06213 1/20 0.40
IGF1R P08069 1/20 0.40
ALK Q9UM73 1/20 0.40
DYRK1A Q13627 5/20 0.39
GSK3B P49841 4/20 0.39
CLK2 P49760 2/20 0.39
CLK3 P49761 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742468 0.93 AURKA (0.50) AURKAFLT3KITABL1BCR
SCHEMBL741957 0.92 AURKA (0.58) AURKAFLT3KITABL1BCR
SCHEMBL741890 0.91 AURKA (0.51) AURKAFLT3KITABL1BCR
SCHEMBL741392 0.89 FLT3 (0.51) AURKAFLT3KITABL1BCR
SCHEMBL741121 0.88 KIT (0.50) AURKAFLT3KITABL1BCR
SCHEMBL739851 0.86 AURKA (0.65) AURKAFLT3KITABL1BCR
SCHEMBL743305 0.85 KIT (0.49) AURKAFLT3KITABL1BCR
SCHEMBL2431632 0.82 KIT (0.57) AURKAFLT3KITNTRK1DYRK1A
SCHEMBL741174 0.81 AURKA (0.54) AURKAFLT3KITABL1BCR
SCHEMBL740581 0.81 ABL1 (0.63) AURKAFLT3KITABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed